These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 7165749

  • 21. Regulators scramble to tighten loopholes after heparin debacle.
    Jia H.
    Nat Biotechnol; 2008 May; 26(5):477-8. PubMed ID: 18464756
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Elimination of contamination from personnel in sterile manufacturing areas.
    Kotaski JA.
    Bull Parenter Drug Assoc; 1971 May; 25(4):203-7. PubMed ID: 5123220
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comment on "Standards for media fill testing.".
    Prout G.
    PDA J Pharm Sci Technol; 1996 May; 50(1):4-5. PubMed ID: 8846057
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [On the use of laminar glow devices in pharmacies (author's transl)].
    Naumann H.
    Pharmazie; 1980 Jan; 35(1):55-60. PubMed ID: 7384177
    [Abstract] [Full Text] [Related]

  • 31. Good validation practices: FDA issues.
    Levchuk JW.
    PDA J Pharm Sci Technol; 1994 Jan; 48(5):221-3. PubMed ID: 8000894
    [No Abstract] [Full Text] [Related]

  • 32. BSE--a risk for man through pharmaceutical products? Position and politics of the German pharmaceutical industry.
    Danner K.
    Dev Biol Stand; 1993 Jan; 80():199-205. PubMed ID: 8270110
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
    J Pharm Sci Technol; 1994 Jan; 48(1):4-6. PubMed ID: 8004417
    [No Abstract] [Full Text] [Related]

  • 36. Gelatine production, the six steps to maximum safety.
    Schrieber R, Seybold U.
    Dev Biol Stand; 1993 Jan; 80():195-8. PubMed ID: 8270109
    [Abstract] [Full Text] [Related]

  • 37. Pharmaceutical GMP: past, present, and future--a review.
    Patel KT, Chotai NP.
    Pharmazie; 2008 Apr; 63(4):251-5. PubMed ID: 18468382
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Particulate matter possible in type B vertical-flow hoods.
    Power LA, Pech JG.
    Am J Hosp Pharm; 1982 Apr; 39(4):574. PubMed ID: 7081230
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.